We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New AI-Based Method Improves Diagnosis of Drug-Resistant Infections

By LabMedica International staff writers
Posted on 09 Apr 2025

Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. More...

These infections are more difficult to treat, often necessitate costlier or more toxic medications, and lead to extended hospital stays and higher mortality rates. In 2021, the World Health Organization (WHO) reported that 450,000 people developed multidrug-resistant tuberculosis, with a treatment success rate falling to just 57%. Current resistance detection methods, employed by organizations such as the WHO, either take too long—such as culture-based testing—or fail to detect rare mutations, as seen with some DNA-based tests. Now, a new artificial intelligence (AI)-based method has been developed to more accurately detect genetic markers of antibiotic resistance in Mycobacterium tuberculosis and Staphylococcus aureus, which could facilitate faster and more effective treatment.

Researchers at Tulane University (New Orleans, LA, USA) have introduced an innovative Group Association Model (GAM), leveraging machine learning to identify genetic mutations associated with drug resistance. Unlike traditional tools that might mistakenly link unrelated mutations to resistance, GAM operates without relying on prior knowledge of resistance mechanisms, making it more adaptable and capable of identifying previously undetected genetic alterations. The model, detailed in Nature Communications, addresses both the slow diagnostic processes and the failure to detect rare mutations by analyzing whole genome sequences. It compares groups of bacterial strains with varying resistance profiles to identify genetic changes that consistently indicate resistance to specific drugs.

In their study, the researchers applied GAM to over 7,000 strains of Mtb and nearly 4,000 strains of S. aureus, identifying crucial mutations linked to resistance. They discovered that GAM not only matched or surpassed the accuracy of the WHO’s resistance database but also significantly reduced false positives, which are incorrect markers of resistance that could lead to improper treatment. The combination of machine learning with GAM also enhanced its predictive capabilities, particularly when working with limited or incomplete data. In validation tests using clinical samples from China, the machine-learning-enhanced model outperformed the WHO-based methods in predicting resistance to critical first-line antibiotics. This breakthrough is important because early detection of resistance allows doctors to adjust treatment regimens appropriately, preventing the infection from worsening or spreading. The model's ability to identify resistance without requiring expert-defined rules also suggests it could be applied to other bacterial infections.

“Current genetic tests might wrongly classify bacteria as resistant, affecting patient care,” said lead author Julian Saliba, a graduate student in the Tulane University Center for Cellular and Molecular Diagnostics. “Our method provides a clearer picture of which mutations actually cause resistance, reducing misdiagnoses and unnecessary changes to treatment.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.